Skip to main content
Clinical Trials/KCT0002226
KCT0002226
Completed
未知

Human study for investigating the effectiveness and safety of Bacillus coagulans SNZ 1969 on intestinal microflora and defecation.

Ewha Womans University0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ewha Womans University
Enrollment
80
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject who voluntarily agrees to participate and sign in informed consent form
  • 2\) Adults (20 years\= Age)
  • 3\) Subject who has defecation difficulty
  • \- According to Rome III criteria(functional constipation)

Exclusion Criteria

  • 1\) Subject who has condition within 1 month as below
  • \- Subject who has taken probiotics, prebiotics (dietary fiber, oligosaccharide) over 1 week consistently.
  • \- Subject who takes antibiotics over 1 week consistently.
  • 2\) Recommended Food Score \> 36
  • 3\) Subject who has symptoms as below or takes related drugs
  • \- irritable bowel syndrome, functional bloating, functional diarrhea
  • \- disease could cause of secondary constipation : hypothyroidism, improperly controlled diabetes, dementia, Parkinson's disease, mental illness(depressive disorder, anorexia nervosa), multiple sclerosis, traumatic vertebra injury, organic disturbance of colon, rectum, anus, pelvis (colorectal cancer, lesion of smooth muscle, rectocele, attenuation of fundus pelvis, intrarectal mucosal prolapse, full\-thickness rectal prolapse, solitary rectal ulcer syndrome) etc.
  • \- severe dysfunction of liver and kidney, alcoholism, cardiovascular disease (including hypertension), immune disease
  • 4\)Subject who has hypersensitivity to dietary supplement or ingredients contained in the supplement.
  • 5\)Subject who has been in clinical demonstration within 1 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials